Literature DB >> 27826997

Real-world costs of ischemic stroke by discharge status.

F Mu1, D Hurley2, K A Betts1, A J Messali1, M Paschoalin3, C Kelley1, E Q Wu1.   

Abstract

OBJECTIVE: The objective of this study was to estimate the acute healthcare costs of ischemic stroke during hospitalization and the quarterly all-cause healthcare costs for the first year after discharge by discharge status.
METHODS: Adult patients with a hospitalization with a diagnosis of ischemic stroke (ICD-9-CM: 434.xx or 436.xx) between 1 January 2006 and 31 March 2015 were identified from a large US commercial claims database. Patients were classified into three cohorts based on their discharge status from the first stroke hospitalization, i.e. dead at discharge, discharged with disability, or discharged without disability. Third-party (medical and pharmacy) and out-of-pocket costs were adjusted to 2015 USD.
RESULTS: A total of 7919 patients dead at discharge, 45,695 patients discharged with disability, and 153,778 patients discharged without disability were included in this analysis. The overall average age was 59.7 years and 52.3% were male. During hospitalization, mean total costs (third-party and out-of-pocket) were $68,370 for patients dead at discharge, $73,903 for patients discharged with disability, and $24,448 for patients discharged without disability (p < .001 for each pairwise comparison); mean third-party costs were $63,605 for patients dead at discharge, $67,861 for patients discharged with disability and $19,267 for patients discharged without disability (p < .001 for each pairwise comparison). During the first year after discharge, mean total costs for patients discharged with disability vs. without disability were $46,850 vs. $30,132 (p < .001). Mean third-party costs for patients discharged with disability vs. without disability were $19,116 vs. $10,976 during the first quarter after discharge, $10,236 vs. $6926 during the second quarter, $8241 vs. $5810 during the third quarter, and $6875 vs. $5292 during the fourth quarter (p < .001 for each quarter).
CONCLUSION: The results demonstrated the high economic burden of ischemic stroke, especially among patients discharged with disability with the highest costs incurred during the inpatient stays.

Entities:  

Keywords:  Healthcare costs; health economics; health insurance reimbursement; stroke

Mesh:

Year:  2016        PMID: 27826997     DOI: 10.1080/03007995.2016.1257979

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  10 in total

1.  A Systematic Review of Direct Cardiovascular Event Costs: An International Perspective.

Authors:  Steve Ryder; Kathleen Fox; Pratik Rane; Nigel Armstrong; Ching-Yun Wei; Sohan Deshpande; Lisa Stirk; Yi Qian; Jos Kleijnen
Journal:  Pharmacoeconomics       Date:  2019-07       Impact factor: 4.981

Review 2.  Blood biomarkers for physical recovery in ischemic stroke: a systematic review.

Authors:  Yun-Ju Lai; Sandra K Hanneman; Rebecca L Casarez; Jing Wang; Louise D McCullough
Journal:  Am J Transl Res       Date:  2019-08-15       Impact factor: 4.060

Review 3.  Brain Functional Reserve in the Context of Neuroplasticity after Stroke.

Authors:  Jan Dąbrowski; Anna Czajka; Justyna Zielińska-Turek; Janusz Jaroszyński; Marzena Furtak-Niczyporuk; Aneta Mela; Łukasz A Poniatowski; Bartłomiej Drop; Małgorzata Dorobek; Maria Barcikowska-Kotowicz; Andrzej Ziemba
Journal:  Neural Plast       Date:  2019-02-27       Impact factor: 3.599

4.  Does service heterogeneity have an impact on acute hospital length of stay in stroke? A UK-based multicentre prospective cohort study.

Authors:  Michelle Tørnes; David McLernon; Max Bachmann; Stanley Musgrave; Elizabeth A Warburton; John F Potter; Phyo Kyaw Myint
Journal:  BMJ Open       Date:  2019-04-03       Impact factor: 2.692

Review 5.  Vascular Cognitive Impairment After Mild Stroke: Connectomic Insights, Neuroimaging, and Knowledge Translation.

Authors:  Jess A Holguin; John L Margetis; Anisha Narayan; Grant M Yoneoka; Andrei Irimia
Journal:  Front Neurosci       Date:  2022-07-07       Impact factor: 5.152

6.  Mechanical thrombectomy for acute ischemic stroke: systematic review and meta-analysis.

Authors:  Ananda Jessyla Felix Oliveira; Sônia Maria Nunes Viana; André Soares Santos
Journal:  Einstein (Sao Paulo)       Date:  2022-08-08

7.  A Systematic Review of the Incidence, Prevalence, Costs, and Activity and Work Limitations of Amputation, Osteoarthritis, Rheumatoid Arthritis, Back Pain, Multiple Sclerosis, Spinal Cord Injury, Stroke, and Traumatic Brain Injury in the United States: A 2019 Update.

Authors:  Jessica Lo; Leighton Chan; Spencer Flynn
Journal:  Arch Phys Med Rehabil       Date:  2020-04-24       Impact factor: 3.966

8.  Implementation and Evaluation of an Economic Model for Telestroke: Experience from Virtuall, France.

Authors:  Nolwenn Riou-Comte; Gioia Mione; Lisa Humbertjean; Arielle Brunner; Arnaud Vezain; Karine Lavandier; Sophie Marchal; Serge Bracard; Marc Debouverie; Sébastien Richard
Journal:  Front Neurol       Date:  2017-11-20       Impact factor: 4.003

9.  The health care utilisation and out-of-pocket expenditure associated with Australian stroke survivors aged 55 and over.

Authors:  David Sibbritt; Mahdie Hosseini; Wenbo Peng; Jessica Bayes; Jon Adams
Journal:  PLoS One       Date:  2022-03-24       Impact factor: 3.240

10.  Beneficial effects of the 30-minute door-to-needle time standard for alteplase administration.

Authors:  Suja S Rajan; Marquita Decker-Palmer; Jessica Wise; Thanh Dao; Cindy Salem; Sean I Savitz
Journal:  Ann Clin Transl Neurol       Date:  2021-07-11       Impact factor: 4.511

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.